| Autor: |
Ayelet Erez, Eytan Ruppin, Igor Ulitsky, Sandesh C.S. Nagamani, Yair Anikster, Raya Eilam, Ben Pode-Shakked, Yehudit Zaltsman-Amir, Keren Bahar Halpern, Erez Persi, Sivan Galai, Noa Stettner, Julia Frug, Alona Sarver, Rom Keshet, Joo Sang Lee, Lital Adler, Shiran Rabinovich, Adi Jacob, Odeya Boukobza Assayag, Omer Goldman, Alon Silberman |
| Rok vydání: |
2023 |
| DOI: |
10.1158/0008-5472.c.6511238.v1 |
| Popis: |
Downregulation of the urea cycle enzyme argininosuccinate synthase (ASS1) by either promoter methylation or by HIF1α is associated with increased metastasis and poor prognosis in multiple cancers. We have previously shown that in normoxic conditions, ASS1 downregulation facilitates cancer cell proliferation by increasing aspartate availability for pyrimidine synthesis by the enzyme complex CAD. Here we report that in hypoxia, ASS1 expression in cancerous cells is downregulated further by HIF1α-mediated induction of miR-224-5p, making the cells more invasive and dependent on upstream substrates of ASS1 for survival. ASS1 was downregulated under acidic conditions, and ASS1-depleted cancer cells maintained a higher intracellular pH (pHi), depended less on extracellular glutamine, and displayed higher glutathione levels. Depletion of substrates of urea cycle enzymes in ASS1-deficient cancers decreased cancer cell survival. Thus, ASS1 levels in cancer are differentially regulated in various environmental conditions to metabolically benefit cancer progression. Understanding these alterations may help uncover specific context-dependent cancer vulnerabilities that may be targeted for therapeutic purposes.Significance:Cancer cells in an acidic or hypoxic environment downregulate the expression of the urea cycle enzyme ASS1, which provides them with a redox and pH advantage, resulting in better survival. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
